Workflow
银河医药混合A
icon
Search documents
爱迪特股价涨5.02%,银河基金旗下1只基金重仓,持有65.06万股浮盈赚取144.43万元
Xin Lang Cai Jing· 2026-01-05 02:38
Group 1 - Aidi Te (Qinhuangdao) Technology Co., Ltd. experienced a stock price increase of 5.02%, reaching 46.42 CNY per share, with a trading volume of 52.22 million CNY and a turnover rate of 1.59%, resulting in a total market capitalization of 4.947 billion CNY [1] - The company, established on March 15, 2007, specializes in the research, production, and sales of internationally competitive zirconia ceramic blocks and other dental restoration materials, with its main business revenue composition being 73.74% from dental restoration materials, 19.80% from dental digital equipment, and 6.46% from other products and services [1] Group 2 - Galaxy Fund has a significant holding in Aidi Te, with the Galaxy Medical Mixed A Fund (011335) holding 650,600 shares, accounting for 5.66% of the fund's net value, making it the eighth largest holding [2] - The Galaxy Medical Mixed A Fund, established on June 17, 2021, has a current size of 503 million CNY and has achieved a year-to-date return of 13.29%, ranking 5344 out of 8155 in its category [2]
机构风向标 | 通化东宝(600867)2025年三季度已披露持仓机构仅9家
Xin Lang Cai Jing· 2025-10-28 02:59
Group 1 - Tsinghua Dongbao (600867.SH) reported its Q3 2025 results, with 9 institutional investors holding a total of 928 million shares, representing 47.39% of the total share capital [1] - The institutional holding ratio increased by 0.77 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, namely the Innovative Medicine fund, increased its holdings slightly, while two funds, including the China Securities National Biomedicine Index A and Southern CSI 500 ETF, reduced their holdings by 0.17% [2] - A total of 249 public funds did not disclose their holdings this period, including Tianhong National Biomedicine ETF and Guotai CSI Biomedicine ETF [2] Group 3 - MACD golden cross signals have formed, indicating a positive trend for certain stocks [3]
机构风向标 | 同和药业(300636)2025年三季度已披露前十大机构持股比例合计下跌1.80个百分点
Xin Lang Cai Jing· 2025-10-25 02:58
Core Insights - Tonghua Dongbao Pharmaceutical (300636.SZ) released its Q3 2025 report on October 25, 2025, indicating a total of 63.9184 million A-shares held by three institutional investors, accounting for 15.22% of the company's total share capital [1] - The institutional holding percentage decreased by 1.80 percentage points compared to the previous quarter [1] Institutional Investors - The three institutional investors include: - Fong Lung Industrial Co., Ltd. - Guotai Junaq Securities' special pension product from China Merchants Bank - Jiangxi Chinese Media Blue Ocean International Investment Co., Ltd. [1] - The total institutional holding ratio stands at 15.22% [1] Public Funds - A total of 58 public funds were not disclosed in the current period compared to the previous quarter, including: - Galaxy Medical Mixed A - Industrial Bank Healthcare A - Galaxy Kang Le Stock A - Fuanda Medical Innovation Mixed - Xiangcai Medical Health Mixed A [1]